Sir -Wyllie et al (1988) in a recent issue suggest, from their observations of c-Ha-ras restriction fragment length polymorphisms (RFLPs) in colorectal cancer, that the extremely high constitutional incidence of rare alleles in breast cancer patients (41% compared with a control value of 9%) found by Lidereau et al (1986) , may have resulted from technical difficulties. We would like to support this suggestion by presenting our own results of c-Ha-ras RFLPs in 80 breast cancer patients (Table I) . Table I Allele distribution of c-Ha-ras in 80 breast cancer patients compared with our control group of 101 (Heighway et al., 1986 (12) 23 (14) 18 (1 1) 5(3) 160
These results show no significant difference in rare allele frequencies between controls and patients (X2=0.143, P=0.706). Although there is a relative increase in a4 alleles in breast cancer patients this is not significant (X2= 1.148, P=0.284) whereas we previously found a significant increase in patients with non-small cell carcinoma of the lung (Heighway et al., 1986) . Wyllie et al. (1988) showed that the sum of a3 and a4 alleles in colorectal cancer patients was significantly higher than in controls but this was not the case for the breast cancer patients in our study (X2= 1.158, P = 0.282).
The problem of migration deviation in Southern blot analysis is stressed by Wyllie et al. (1988) and we too have observed a slight shift in allele position in tumour samples when comparing tumour and peripheral blood DNA.
Tumour DNA is often more impure and may be slightly degraded when compared to that obtained from peripheral blood samples. This could result in either partial digests or unbalanced DNA loadings at a particular position in a gel causing a band to appear at a slightly different molecular weight. In the study of Lidereau et al. (1986) 
